This study set out to access the performance of quantitative analysis of contrast-enhanced ultrasound (CEUS) indistinguishing between benign periablational enhancement (BPE) and residual tumor (RT) following radiofrequency ablation(RFA). 165 tumors from 124 patients with hepatocellular carcinoma between 2021 and 2023underwent RFA, contrast-enhanced computed tomography (CECT), and CEUS in less than 24 hours. Analysis was done onthe quantitative parameters from RT and BPE found by CEUS. Complete ablation was obtained in 89.1% of lesions.When compared to BPE, RT had significantly greater peak intensity (PI), time to peak (TTP), area under the curve (AUC),ratio of PI and base intensity (PI/BI), and enhanced intensity (EI) values (all p<0.05). PI, TTP, AUC, PI/BI, and EI had largeareas under the receiver operating (ROC) curves. A binary logistic regression analysis, respectively, demonstrated that PI andPI/BI were independent favorable prognostic variables. Multiple parameters of quantitative analysis of CEUScan aid in distinguishing immediately between RT and BPE lesions. PI and PI/BI may be a more promising parameter. ImmediateCEUS evaluation following RFA may allow immediate retreatment of RT during the same operation time, which reducespatients' hospital stays and financial costs.
Read full abstract